DEF: Profusa Seeks $100M ELOC for Bitcoin Investment

Profusa, Inc. is seeking stockholder approval for an Equity Line of Credit of up to $100 million with Ascent Partners Fund LLC, primarily to fund Bitcoin purchases.

Summary

• A Special Meeting of Stockholders will be held on August 29, 2025, to vote on a proposal to approve an Equity Line of Credit (ELOC) transaction.
• The ELOC allows Profusa to issue and sell shares of its common stock to Ascent Partners Fund LLC for an aggregate purchase price of up to $100,000,000.
• This approval is sought to comply with Nasdaq Listing Rule 5635(d), which requires stockholder authorization for issuances exceeding 19.99% of outstanding shares at a price below certain thresholds.
• The purchase price per share will be 97% of the lowest volume-weighted average price (VWAP) of the Company's common stock during a 10-day valuation period, subject to a floor price and other adjustments.
• Sales under the ELOC are at the Company's sole discretion and can occur from time to time until July 28, 2028.
• The Company expects to use any proceeds primarily for the purchase of Bitcoin, subject to maintaining a minimum cash balance.
• As consideration for Ascent's commitment, Profusa issued Commitment Warrants to Ascent to purchase up to 900,000 shares at an exercise price of $0.01.
• The Board of Directors recommends that stockholders vote FOR the ELOC proposal, stating it provides a reliable source of capital.

Sentiment

Score: 5

Explanation: The ELOC provides a crucial capital source, which is positive for liquidity and business continuity. However, the significant potential for dilution, the use of proceeds for Bitcoin (introducing new market volatility risks), and the necessity of stockholder approval for full utilization introduce considerable uncertainty and potential downside for existing shareholders. It's a necessary but potentially costly financing mechanism.

Positives

• Provides a reliable and flexible source of capital, allowing the Company to access funds at its discretion based on market conditions and funding needs.
• The ELOC can provide up to $100,000,000 in funding, which is crucial for the Company's ongoing business needs and strategic plans.
• The ability to fund strategic initiatives, specifically Bitcoin purchases, could be seen as a positive by investors interested in digital asset exposure.

Negatives

• The sale of shares under the ELOC will have a dilutive effect on existing stockholders' voting power and economic rights.
• Ascent Partners Fund LLC may resell purchased shares at different times and prices, potentially leading to varying and substantial dilution for investors.
• The Company is obligated to reimburse Ascent for costs, fees, and expenses up to $30,000 related to the agreement.
• Failure to obtain stockholder approval will limit the Company's ability to fully utilize the $100 million ELOC, potentially forcing it to seek alternative financing on less advantageous terms or not at all.

Risks

• Dilution Risk: Future sales of common stock under the ELOC will dilute the voting power and economic rights of existing stockholders.
• Market Price Risk: The purchase price for shares is tied to a discount from VWAP, meaning shares could be sold at prices below current market value, especially if the stock price declines.
• Financing Risk: If stockholder approval is not obtained, the Company may be unable to fully utilize the ELOC, potentially leading to a need for alternative financing that may not be available on favorable terms or at all.
• Operational Impact Risk: Inability to raise sufficient capital could materially and adversely impact future operating results, and result in a delay in or modification or abandonment of business plans.
• Bitcoin Investment Risk: The primary use of proceeds for Bitcoin purchases introduces exposure to the volatile and speculative cryptocurrency market, which carries significant price and regulatory risks.
• Nasdaq Compliance Risk: Failure to comply with Nasdaq rules regarding share issuances could impact the Company's listing status.

Future Outlook

The Company expects that any proceeds received from sales under the ELOC will be used primarily for the purchase of Bitcoin, subject to a minimum cash balance requirement, and to maintain a minimum cash balance. The ability to successfully implement business plans and generate stockholder value is dependent on raising capital and satisfying ongoing business needs.

Management Comments

• Our Board believes that the approval of the ELOC transaction is advisable and in the best interests of the Company and its stockholders and recommends that you vote FOR the ELOC transaction.
• The Board has determined that the Purchase Agreement with Ascent is in the best interests of the Company and its stockholders because the right to sell shares to Ascent provides the Company with a reliable source of capital and the ability to access that capital at such times that the Company determines is appropriate.

Industry Context

This filing indicates Profusa's strategic pivot towards incorporating Bitcoin into its treasury management, a trend observed in a limited number of public companies seeking to diversify their balance sheets or leverage cryptocurrency as an alternative asset. The use of an Equity Line of Credit is a common financing mechanism for growth-stage companies or those seeking flexible capital without immediate large-scale equity offerings, particularly when market conditions for traditional raises are challenging. The explicit mention of Bitcoin acquisition as a primary use of funds positions Profusa uniquely compared to typical biotech or medical device companies, aligning it more with companies exploring digital asset strategies.

Comparison to Industry Standards

• The decision to use an Equity Line of Credit (ELOC) is a common financing strategy for smaller or growth-stage companies, similar to how MicroStrategy (MSTR) has utilized various financing methods, including convertible notes, to fund its Bitcoin acquisition strategy. However, MicroStrategy's scale and established Bitcoin holdings are significantly larger.
• The 97% of VWAP pricing mechanism is standard for ELOCs, offering a discount to market price to incentivize the investor, comparable to similar agreements seen with institutional investors like Lincoln Park Capital or Aspire Capital in the small-cap market.
• The 9.99% beneficial ownership cap for Ascent Partners Fund LLC is a typical protective measure to avoid triggering certain reporting requirements or change of control provisions, a common clause in such financing agreements.
• The explicit allocation of proceeds to Bitcoin purchases differentiates Profusa from most companies in the medical technology or biotech sector, where capital is typically earmarked for R&D, clinical trials, or commercialization. This strategy is more akin to a treasury management decision seen in companies like Tesla (TSLA) or Block (SQ) that have integrated Bitcoin into their corporate treasuries, though Profusa's primary business is not cryptocurrency-related.

Stakeholder Impact

• Shareholders: Significant potential for dilution of voting power and economic rights due to future share issuances. The value of their holdings could be impacted by the pricing mechanism and Ascent's resale activities.
• Company Operations: Access to capital from the ELOC is crucial for the Company's ability to satisfy ongoing business needs and implement its business plans, potentially preventing delays or abandonment of initiatives.
• Creditors: A successful capital raise could improve the Company's financial stability, potentially reducing credit risk.

Next Steps

• Hold a Special Meeting of Stockholders on August 29, 2025, to vote on the ELOC proposal.
• If approved, the Company may, at its discretion, issue and sell shares to Ascent Partners Fund LLC under the ELOC until July 28, 2028.
• The Company plans to use proceeds primarily for Bitcoin purchases.
• The Company is required to file a registration statement covering the resale of shares by Ascent and maintain its effectiveness.

Key Dates

Recommendation

The proposed Equity Line of Credit provides Profusa with a vital source of capital, which is essential for its ongoing operations and strategic initiatives, including the stated intent to purchase Bitcoin. This access to funding mitigates immediate liquidity concerns. However, the significant potential for dilution from the issuance of up to $100 million in common stock, coupled with the inherent volatility and speculative nature of Bitcoin investments, introduces substantial risk for existing shareholders. While the capital infusion is positive for the company's runway, the dilutive effect and the non-core asset allocation warrant caution. A 'hold' recommendation is appropriate as investors should monitor the actual utilization of the ELOC, the impact of dilution, and the performance of the Bitcoin investment before making further commitments.

Keywords

Profusa, ELOC, Equity Line of Credit, Ascent Partners Fund, Nasdaq Listing Rule 5635(d), Stockholder Approval, Dilution, Capital Raise, Bitcoin Investment, Proxy Statement, Common Stock, Warrants